|
|
Healthcare Fraud Shield job openings!
|
Healthcare Fraud Shield's Upcoming Presentations
Click HERE to see where Healthcare Fraud Shield staff will be exhibiting, speaking or attending events!
|
|
Dear Healthcare Fraud Shield Reader:
Our articles are written by our team of Subject Matter Experts. Th
is week's article was written by our very own Debbie Brandenburg, RN, BSN AHFI, CPC, CPMA, CEMC. See more information on
What's in the Cup (Urine Drug Screening)?
As a remi
nder you can go to the
Healthcare Fraud Shield blog
where you can access all of our previous articles.
Sincerely,
Healthcare Fraud Shield
|
What's in the Cup (Urine Drug Screening)?
With the focus on the Opioid crisis in this country and the increasing number of overdoses and deaths, prescription drugs have come under closer scrutiny. It is not just a billing issue, but also a patient care and safety issue. With those thoughts in mind, let's take a look at Pain Management and the use of Urine Drug Screening (UDS).
A pain management physician may employ various means to address the patient's complaint(s). The Centers for Disease Control (CDC) published Clinical Guidelines for prescribing opioids for chronic pain.
[i] When narcotics are employed in the treatment of pain, UDS is an important component of the treatment regimen. Not only can a UDS provide the physician with an accurate picture of the member's compliance with the prescribed medications, but it can also aid in the detection of drug diversion, drug supplementing, and the use of illicit drugs
[ii].
According to the American Academy of Pain Medicine, UDS must be ordered by the treating physician or Nonphysician provider (NPP). In your assessment of billing data and the medical record, you should see both scheduled and random testing.
The
SAMHSA UDS Collection Guidelines
also stipulate that standards must be established to ensure that the specimen tested
is
the patient's current sample and not altered.
[iii]
Scheduled Point of Contact UDS testing (e.g., every 3 months at the office appointment) is typically NOT sufficient to provide the physician with an accurate assessment of the patient's prescription compliance, as it allows the non-compliant patient sufficient time to defeat the accuracy of UDS tests.
[iv] Most payers (commercial, state, and federal) have established policies concerning UDS coverage. Please refer to your respective policies and regulations. However, the following are typical expected and unexpected findings when looking at pain management and UDS:
Expected
|
Unexpected
|
The patient is under the care of a Board-Certified Pain Management provider/service;
|
Billing of
both presumptive and definitive UDS testing on each date of service;
|
The billing of a presumptive (qualitative) UDS and/or definitive (quantitative) UDS at the initial point of care;
|
Billing of the
same definitive UDS CPT codes every time
|
Billing of a minimum of four (4) UDS tests/12-month period
|
Billing of
a large number of definitive test codes without support in the encounter note;
|
A presumptive test is the first method of choice when testing (Usually with CPT codes 80305, 80306, or 80307)
|
Billing of presumptive and/or definitive UDS testing at regular intervals without exception (i.e., every 3 months). UDS testing should also be random and not "just" Point of Contact testing during regular office visits.
|
Definitive testing is performed when presumptive results demonstrate abnormal or inconsistent findings, or the provider suspects the patient is not compliant with the prescription regimen.
|
No documentation of accuracy of specimen (Specific gravity, pH, Creatinine, specimen temperature, color, volume), no chain of custody documentation
|
The UDS results are documented in the patient's medical record, noted in a timely manner, and incorporated into the patient's treatment plan.
|
No incorporation of the UDS results in the patient's treatment regimen.
|
If you would like to learn more about Healthcare Fraud Shield's analytics solution, contact us at [email protected].
|
|
About Healthcare Fraud Shield
Healthcare Fraud Shield is based in Chesterfield, Missouri and provides advanced FWA (Fraud, Waste and Abuse) detection systems to the healthcare industry. The company's services enable investigators to quickly identify suspicious activity and accurately pinpoint fraud. Our unique technology allows our customers to maximize loss prevention and recovery efforts with a substantial ROI.
16052 Swingley Ridge Road, Suite 200,
Chesterfield, Missouri 63017
|
|
|
|
|
|